NZ192453A - N-aryl-n-(2-imidazoldinylidene)-urea compounds - Google Patents
N-aryl-n-(2-imidazoldinylidene)-urea compoundsInfo
- Publication number
- NZ192453A NZ192453A NZ192453A NZ19245379A NZ192453A NZ 192453 A NZ192453 A NZ 192453A NZ 192453 A NZ192453 A NZ 192453A NZ 19245379 A NZ19245379 A NZ 19245379A NZ 192453 A NZ192453 A NZ 192453A
- Authority
- NZ
- New Zealand
- Prior art keywords
- imidazoldinylidene
- aryl
- urea compounds
- urea
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/972,579 US4229462A (en) | 1978-12-22 | 1978-12-22 | Method for controlling hypertension and compositions |
US05/972,580 US4239768A (en) | 1978-12-22 | 1978-12-22 | Method for relieving irritable bowel syndrome symptoms |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ192453A true NZ192453A (en) | 1982-09-07 |
Family
ID=27130555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ192453A NZ192453A (en) | 1978-12-22 | 1979-12-18 | N-aryl-n-(2-imidazoldinylidene)-urea compounds |
Country Status (23)
Country | Link |
---|---|
AT (1) | AT373878B (ru) |
AU (2) | AU532332B2 (ru) |
CA (1) | CA1127651A (ru) |
CH (1) | CH647236A5 (ru) |
DE (1) | DE2951213A1 (ru) |
DK (1) | DK548179A (ru) |
ES (1) | ES487159A0 (ru) |
FI (1) | FI66354C (ru) |
FR (2) | FR2444462B1 (ru) |
GB (2) | GB2040681B (ru) |
GR (1) | GR68018B (ru) |
HU (1) | HU183013B (ru) |
IL (1) | IL59019A (ru) |
IT (1) | IT1126839B (ru) |
NL (1) | NL7909265A (ru) |
NO (1) | NO794249L (ru) |
NZ (1) | NZ192453A (ru) |
PH (1) | PH16571A (ru) |
PT (1) | PT70624A (ru) |
SE (1) | SE7910612L (ru) |
SU (1) | SU971098A3 (ru) |
YU (1) | YU314979A (ru) |
ZW (1) | ZW25379A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673680A (en) * | 1985-09-18 | 1987-06-16 | Pendleton Robert G | α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
US11516649B2 (en) * | 2018-10-29 | 2022-11-29 | Apple Inc. | Mechanism to activate and manage a standalone device for cellular service |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1296962A (fr) * | 1960-08-05 | 1962-06-22 | Geigy Ag J R | Nouveaux composés 2-imino-1.3-di-aza et leur préparation |
NL267923A (ru) * | 1960-08-05 |
-
1979
- 1979-12-06 CA CA341,351A patent/CA1127651A/en not_active Expired
- 1979-12-06 GR GR60697A patent/GR68018B/el unknown
- 1979-12-13 AU AU53780/79A patent/AU532332B2/en not_active Ceased
- 1979-12-13 PH PH23413A patent/PH16571A/en unknown
- 1979-12-18 NZ NZ192453A patent/NZ192453A/xx unknown
- 1979-12-19 DE DE19792951213 patent/DE2951213A1/de not_active Ceased
- 1979-12-20 DK DK548179A patent/DK548179A/da not_active Application Discontinuation
- 1979-12-20 ES ES487159A patent/ES487159A0/es active Granted
- 1979-12-21 CH CH11419/79A patent/CH647236A5/de not_active IP Right Cessation
- 1979-12-21 YU YU03149/79A patent/YU314979A/xx unknown
- 1979-12-21 GB GB7944114A patent/GB2040681B/en not_active Expired
- 1979-12-21 SU SU792860905A patent/SU971098A3/ru active
- 1979-12-21 HU HU79MA3254A patent/HU183013B/hu unknown
- 1979-12-21 FI FI794036A patent/FI66354C/fi not_active IP Right Cessation
- 1979-12-21 NL NL7909265A patent/NL7909265A/nl not_active Application Discontinuation
- 1979-12-21 AT AT0808979A patent/AT373878B/de active
- 1979-12-21 IT IT51164/79A patent/IT1126839B/it active
- 1979-12-21 NO NO794249A patent/NO794249L/no unknown
- 1979-12-21 PT PT70624A patent/PT70624A/pt unknown
- 1979-12-21 ZW ZW253/79A patent/ZW25379A1/xx unknown
- 1979-12-21 FR FR7931473A patent/FR2444462B1/fr not_active Expired
- 1979-12-21 SE SE7910612A patent/SE7910612L/xx not_active Application Discontinuation
- 1979-12-21 IL IL59019A patent/IL59019A/xx unknown
-
1980
- 1980-04-04 FR FR8007757A patent/FR2445321B1/fr not_active Expired
-
1982
- 1982-07-26 GB GB08221517A patent/GB2113204B/en not_active Expired
-
1983
- 1983-06-29 AU AU16400/83A patent/AU566013B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG13913A (en) | Novel n-heterocyclyl-4-piperidinamines | |
JPS54119486A (en) | 66substituted thiaaaza compound | |
JPS5592393A (en) | Aminoorganosiliconacylamino compound | |
GB2025666B (en) | Case for atimepiece | |
GB2025999B (en) | Bistrialkoxysiloxy - silane compound | |
PH14716A (en) | 3-substituted-5-vinyl-2-pyrrolidone compounds | |
GB2031425B (en) | 3-unsubstituted-3-cephem compounds | |
JPS54163582A (en) | 22phenoxyy55 trifluoromethypiridine compound | |
JPS54160397A (en) | Antiirhinouiruse compound | |
JPS54138524A (en) | Boronnsilicon compound | |
GB2020279B (en) | Piperazinylbenzoheterocyclic compounds | |
JPS54138522A (en) | Sulfonateeorganosilanol compound | |
ZA792633B (en) | Flukicidal compounds | |
JPS54141766A (en) | Antiiinflammatory compound | |
JPS5536471A (en) | Spiroketaline compound | |
JPS54125625A (en) | 33hydroxybenzyl compound | |
JPS54128538A (en) | 44nitroo22trichlormethyllphenyldisulfide compound | |
JPS5559193A (en) | Bblactam compound | |
IL56814A (en) | 2-decarboxy-2-alkylcarbonyl-prostaglandin compounds | |
JPS554400A (en) | Hindereddphenol compound | |
JPS5553271A (en) | Novel acylaminoo1*44dihydropyridine compound | |
GB2021680B (en) | Latch-and-keeper mechanisms | |
ZA792467B (en) | Furonaphthyridine compounds | |
ZA791714B (en) | Piperazinylbenzoheterocyclic compounds | |
JPS54151989A (en) | 44pyrimidylsulfide compound |